Aktive Positionen von Elmar Schärli
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Xigen SA
Xigen SA Pharmaceuticals: MajorHealth Technology Xigen SA develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer. It focuses on the acute or short-term treatment of major debilitating pathologies that underly unmet medical needs plaguing humanity. The company was founded in 2002 and is headquartered in Epalinges, Switzerland. | Finanzdirektor/CFO | - | - |
Zilentin AG
Zilentin AG Pharmaceuticals: MajorHealth Technology Zilentin AG develops projects for the treatment of tinnitus and hearing loss. The company is headquartered in Zug, Switzerland. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Elmar Schärli
Ehemalige bekannte Positionen von Elmar Schärli
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALTAMIRA THERAPEUTICS LTD. | Finanzdirektor/CFO | 01.11.2019 | 01.11.2021 |
Statistik
International
Schweiz | 3 |
Bermuda | 2 |
Operativ
Director of Finance/CFO | 2 |
Director/Board Member | 1 |
Sektoral
Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ALTAMIRA THERAPEUTICS LTD. | Health Technology |
Private Unternehmen | 2 |
---|---|
Xigen SA
Xigen SA Pharmaceuticals: MajorHealth Technology Xigen SA develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer. It focuses on the acute or short-term treatment of major debilitating pathologies that underly unmet medical needs plaguing humanity. The company was founded in 2002 and is headquartered in Epalinges, Switzerland. | Health Technology |
Zilentin AG
Zilentin AG Pharmaceuticals: MajorHealth Technology Zilentin AG develops projects for the treatment of tinnitus and hearing loss. The company is headquartered in Zug, Switzerland. | Health Technology |
- Börse
- Insiders
- Elmar Schärli
- Erfahrung